If a patient s cancer is HR and HER2, clinicians may recommend either HER2 targeted therapy plus chemotherapy type evidence based; evidence quality high; strength of recommendation strong, endocrine therapy with trastuzumab or lapatinib type evidence based; evidence quality high; strength of recommendation moderate, or endocrine therapy alone in selected cases type evidence based; evidence quality intermediate; strength of recommendation weak nolvadex.lol - buy nolvadex In one aspect, the viscosity enhancing agent comprises povidone, hydroxypropylmethylcellulose, hydroxypropylcellulose, gelatin, methylcellulose, acacia, xanthan gum, or tragacanth